<DOC>
	<DOCNO>NCT02352701</DOCNO>
	<brief_summary>This study compare efficacy safety basic triple therapy include Ilaprazole 10mg , Levofloxacin 500mg Amoxicillin 1000mg BID 10 day first line eradication treatment H.pylori</brief_summary>
	<brief_title>Efficacy Safety Basic Triple Therapy Including Ilaprazole First Line Eradication Treatment H.Pylori</brief_title>
	<detailed_description>This study compare efficacy safety basic triple therapy include Noltec ( Ilaprazole ) 10mg , Cravit ( Levofloxacin ) 500mg Chongkundang Amoxicillin Cap ( Amoxicillin ) 1000mg BID first line eradication treatment H.pylori . Participants define person endoscopically confirm gastric duodenal ulcer ( include scar stage ) gastritis confirm H.pylori positive patient biopsy UBT test . For 10 day , Participants treat basic triple therapy include Noltec ( Ilaprazole ) 10mg , Cravit ( Levofloxacin ) 500mg Chongkundang Amoxicillin Cap ( Amoxicillin ) 1000mg BID . After treatment , The heal rate evaluate UBT test Biopsy 49Â±5days first day dosing .</detailed_description>
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Subject must endoscopically confirm gastric , duodenal ulcer ( include scar ) gastritis confirm H.pylori positive patient biopsy UBT test . Subject fully understand condition clinical trial . Subject agree participate spontaneously sign ICF Known hypersensitivity component ilaprazole , Amoxicillin Levofloxacin Subjects take contraindicated medication experimental concomitant drug . Patients abnormal level laboratory test Total Bilirubin , Creatinine &gt; 1.5 time upper limit normal AST , ALT , Alkaline phosphatase , BUN &gt; 2 time upper limit normal Administrated PPI , antibiotic medication within 4 week prior commencement study . Pregnant and/or lactate woman Reproductive age woman use contraception Uncontrolled diabetic Uncontrolled hypertension Uncontrolled liver dysfunction Alcoholics Subjects history digestive malignancy within 5 year Subjects history gastrectomy esophagectomy Subjects hereditary disease Galactose intolerance , Lapp lactose deficiency , glucosegalactose malabsorption . Subjects participate clinical trial another trial wihin 30 day Inconsistence judge subject researcher</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>helicobacter pylorus</keyword>
	<keyword>ilaprazole</keyword>
	<keyword>eradication</keyword>
	<keyword>triple therapy</keyword>
</DOC>